Japan Withdraws HPV Vaccination Support for Fertility Reasons

Holy Hormones Journal: Well, holy hormones honey! Japan takes the world by surprise – rocks Merck, WHO, the Bill & Melinda Gates Foundation by announcing that they value their women and their fertility and do not want to jeopardize the lives of any more women who could be potentially injured by Gardasil.  In other words, the health ministry of Japan is listening to the families of girls who have been severely injured by the HPV vaccines.  Where is our government? The CDC, FDA, and NCI?  The Health Ministry of Japan has put them to shame… as well as every other government in the western world.

So ok – Japan does have its own interests to protect and that is the future of their country.  It appears that nations around the world who have embraced the technologies and the conveniences of the western world – are now facing an increase in infertility rates.  This puts their country’s population at risk since many have an aging populace.  Singapore Worried About Declining Fertility Rates – Is This an Emerging Global Trend?

The National Vaccine Information Center published some very disturbing data in April of 2013 – noting that the HPV vaccine has noticeable spikes in cardiac, nervous system, pregnancy, and vascular disorders.

Gardasil Shocker: Japan Withdraws Support for HPV Vaccine

by Sarah, The Healthy Home Economist
June 16, 2013


Japan suffers from one of the lowest fertility rates in the world – 1.39 (2011)  – well below 2.1 population replacement level. This combined with a rapidly aging populace has become such a worry for the government that women are actually now being paid to have babies.

According to the Wall Street Journal, a Japanese program that pays new parents $3,300 per year for every new child until age 15, along with offering less direct incentives, like state-supported daycare and tuition waivers, was implemented in 2009.

The result?  The fertility rate barely budged.

With cash offers for babies not yet working, Japan is being extremely cautious in implementing any long term health initiatives which affect women’s reproductive organs.

On June 14, 2013, Japan’s health ministry raised eyebrows around the world by deciding to formally withdraw its recommendation for HPV vaccination (Gardasil, Cervarix) to protect girls against cervical cancer.

The reason? Hundreds of complaints from Japanese citizens about possible side effects such as long-term pain, numbness and even paralysis.

In an attempt to avoid completely alienating the World Health Organization, which recommends the HPV vaccine used by many developed nations, the Ministry of Health, Labor and Welfare insisted that it is not suspending the use of the vaccine, but simply instructed local Japanese governments not to promote it until more study is conducted on its safety.

Mariko Momoi, vice president of the International University of Health and Welfare, who headed the task force on the matter said:

“The decision (not to recommend the vaccination) does not mean that the vaccine itself is problematic from the viewpoint of safety. By implementing investigations, we want to offer information that can make the people feel more at ease.”

Blah, blah, blah.  The best government-speak in the world doesn’t drown out this message which is LOUD and clear.  The Japanese health ministry doesn’t trust the HPV vaccines Gardasil or Cervarix.

It is important to note that it is rare for the Japanese health ministry to withdraw a recommendation for a vaccine that is used regularly by local governments and is spelled out as part of revisions to the Preventative Vaccination Law approved in April 2013.

Read full article…


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.